LFVN Lifevantage

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against LifeVantage Corporation - LFVN

NEW YORK--(BUSINESS WIRE)--

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of LifeVantage Corporation (NASDAQ: LFVN) resulting from allegations that LifeVantage may have issued materially misleading business information to the investing public.

On September 13, 2016, LifeVantage disclosed that it was delaying the release of its fourth quarter and fiscal year 2016 financial results. The delay is due to LifeVantage’s review of its sales into certain international markets and the revenue and income tax and the associated accruals. On this news, shares of LifeVantage fell sharply during intraday trading on September 14, 2016.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by LifeVantage investors. If you purchased shares of LifeVantage on or before September 13, 2016, please visit the firm’s website at http://www.rosenlegal.com/cases-952.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

EN
14/09/2016

Underlying

LFVNLifevantage

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage to Participate in Water Tower Fireside Chat on Thursday, D...

LifeVantage to Participate in Water Tower Fireside Chat on Thursday, December 11, 2025 SALT LAKE CITY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the upcoming Water Tower Fireside Chat Series on Thursday, December 11, 2025. The webcast of the fireside chat will begin at approximately 2:00 p.m. Eastern Time on...

December 10, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

New Study Finds LifeVantage's P84 Positively Impacts Gut Peptide Produ...

New Study Finds LifeVantage's P84 Positively Impacts Gut Peptide Production, Activating Key Elements for Comprehensive Gut Health New in vitro research shows P84 influences key gut peptides – including one by more than 1,000% – supporting cellular pathways tied to regulation, repair, and restoration SALT LAKE CITY, Nov. 12, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced new in vitro study results for its proprietary P84 formula revealing strong biological a...

November 12, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid December 15, 2025 to all stockholders of record at the close of business on December 1, 2025. About LifeVantage Corporation LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a p...

November 4, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage Announces Financial Results for the First Quarter of Fisca...

LifeVantage Announces Financial Results for the First Quarter of Fiscal 2026 SALT LAKE CITY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2025. First Quarter Fiscal 2026 Summary*: Revenue was $47.6 million, an increase of 0.7% from the prior year period. Excluding the impact of foreign currency fluctuations, first quarter revenue increased approximately 0.3%;...

November 4, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage Empowers Consultants to “Love Life & Drive” at Momentum Ac...

LifeVantage Empowers Consultants to “Love Life & Drive” at Momentum Academy 2025 Dallas event delivers new products, tools, and business strategies designed to accelerate performance and leadership SALT LAKE CITY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful conclusion of , a dynamic, high-impact event that brought together thousands of Consultants from across the U.S. from October 23-25 at the Hilton Anatole in Dallas, TX. This...

October 28, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch